According to the analysis data of China pharmaceutical industry's economic operation in the first half of 2007 released by the National Development and Reform Commission, the pharmaceutical industry began to pick up in the first half of this year. This is the first time that the pharmaceutical industry has shown signs of rebound since the previous two years. In the first half of this year, the operation of the pharmaceutical industry was characterized by rapid growth in production and sales and more income. From June to June this year, the total industrial output value was 3 1000 billion yuan, a year-on-year increase of 22.5%. Among them, the growth rate of sub-sectors such as Chinese herbal pieces processing, sanitary materials and medical supplies, chemical raw materials, biochemical drugs and medical devices and equipment manufacturing is higher than the average level of the whole industry; The sales output value was 29 1.3 billion yuan, up 22.7% year-on-year. At the same time, from June 5438 to May, the profit of the whole industry was 198 billion yuan, up 36 1% year-on-year, the best level since the Tenth Five-Year Plan. According to the annual data of SFDA Southern Institute of Pharmaceutical Economics, the overall benefit of China's pharmaceutical industry improved significantly in the first half of this year. It is estimated that the total output value of the pharmaceutical industry will exceed 600 billion yuan, with a year-on-year increase of 17.8% ~ 18.5%, and the whole industry is still growing steadily.